间充质基质细胞通过细胞外囊泡线粒体转移调控肺损伤模型中的巨噬细胞
本研究探讨人间充质基质细胞(MSC)对ARDS环境下巨噬细胞功能的旁分泌效应及细胞外囊泡(EV)介导的线粒体转移机制。MSC可抑制LPS或ARDS BALF刺激的人单核来源巨噬细胞因子产生、增加M2标志物表达并增强吞噬能力,该效应部分由表达CD44的EV介导;经MSC来源EV预处理的小鼠肺泡巨噬细胞过继转移可减轻LPS损伤小鼠的炎症和肺损伤。
要点
- MSC通过EV介导的线粒体转移促进巨噬细胞抗炎和高吞噬表型。
- MSC对巨噬细胞的调控依赖于增强巨噬细胞氧化磷酸化。
- MSC来源EV预处理的肺泡巨噬细胞过继转移可减轻小鼠肺损伤。
核心结论
- 在ARDS环境中,MSC通过EV介导的线粒体转移促进抗炎且高吞噬能力的巨噬细胞表型。
- MSC诱导的巨噬细胞表型变化关键依赖于增强巨噬细胞氧化磷酸化。
- 经MSC来源EV处理的肺泡巨噬细胞可在体内改善肺损伤。
研究设计与样本
- 研究人单核来源巨噬细胞(MDM)与人间充质基质细胞(MSC)在LPS或ARDS患者支气管肺泡灌洗液(BALF)刺激下的非接触共培养。
- 小鼠肺泡巨噬细胞(AM)体外与或不与人MSC来源细胞外囊泡(EV)共培养后,过继转移至LPS损伤小鼠。
主要发现
- MSC抑制LPS或ARDS BALF刺激的人MDM的细胞因子产生,增加M2巨噬细胞标志物表达,并增强吞噬能力。
- 上述效应部分由表达CD44的EV介导。
- 经MSC来源EV预处理的小鼠AM过继转移可减轻LPS损伤小鼠的炎症和肺损伤。
- 抑制MDM氧化磷酸化可阻止MSC的调控效应。
- 用罗丹明6G预处理MSC以产生功能失调的线粒体,也可消除这些效应。
临床怎么用
- MSC来源EV可能作为ARDS中调控巨噬细胞表型的潜在治疗策略。
- MSC疗效机制涉及EV介导的线粒体转移和巨噬细胞氧化磷酸化增强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Acute respiratory distress syndrome (ARDS) remains a major cause of respiratory failure in critically ill patients. Mesenchymal stromal cells (MSCs) are a promising candidate for a cell-based therapy. However, the mechanisms of MSCs' effects in ARDS are not well understood. In this study, we focused on the paracrine effect of MSCs on macrophage polarization and the role of extracellular vesicle (EV)-mediated mitochondrial transfer. OBJECTIVES: To determine the effects of human MSCs on macrophage function in the ARDS environment and to elucidate the mechanisms of these effects. METHODS: Human monocyte-derived macrophages (MDMs) were studied in noncontact coculture with human MSCs when stimulated with LPS or bronchoalveolar lavage fluid (BALF) from patients with ARDS. Murine alveolar macrophages (AMs) were cultured ex vivo with/without human MSC-derived EVs before adoptive transfer to LPS-injured mice. MEASUREMENTS AND MAIN RESULTS: MSCs suppressed cytokine production, increased M2 macrophage marker expression, and augmented phagocytic capacity of human MDMs stimulated with LPS or ARDS BALF. These effects were partially mediated by CD44-expressing EVs. Adoptive transfer of AMs pretreated with MSC-derived EVs reduced inflammation and lung injury in LPS-injured mice. Inhibition of oxidative phosphorylation in MDMs prevented the modulatory effects of MSCs. Generating dysfunctional mitochondria in MSCs using rhodamine 6G pretreatment also abrogated these effects. CONCLUSIONS: In the ARDS environment, MSCs promote an antiinflammatory and highly phagocytic macrophage phenotype through EV-mediated mitochondrial transfer. MSC-induced changes in macrophage phenotype critically depend on enhancement of macrophage oxidative phosphorylation. AMs treated with MSC-derived EVs ameliorate lung injury in vivo.
引用
- Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Am J Respir Crit Care Med. 2017. PMID: 28598224. doi:10.1164/rccm.201701-0170OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。